DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Intron A (Interferon Alfa-2B) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Intron A (Interferon Alfa-2B) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-17

Patient: female

Reactions: Drug Ineffective, Condition Aggravated, Suicidal Ideation, Malaise, Bipolar I Disorder, Dehydration, Asthenia, Blister

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Intron A
    Indication: Hepatitis C
    Start date: 2011-10-10
    End date: 2011-11-18

Intron A
    Indication: Hepatitis C
    Start date: 1991-01-01
    End date: 1991-04-01

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-10-10
    End date: 2011-11-18

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-10-10
    End date: 2011-11-18



Possible Intron A side effects in 38 year old male

Reported by a consumer/non-health professional from Spain on 2012-01-11

Patient: 38 year old male

Reactions: Migraine, Economic Problem, Drug Ineffective, Pain, Encephalitis, Liver Disorder, Osteoarthritis, Alopecia, Tendonitis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 1996-01-01

Intron A
    Dosage: 100000 iu
    Indication: Hepatitis C
    Start date: 1996-01-01



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-01

Patient: female

Reactions: Drug Ineffective, Skin Disorder, Suicidal Ideation, Malaise, Bipolar I Disorder, Dehydration, Asthenia, Blister

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 2011-10-10
    End date: 2011-11-18

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-10-10
    End date: 2011-11-18

Intron A
    Indication: Hepatitis C
    Start date: 1991-01-01
    End date: 1991-04-01



Possible Intron A side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-23

Patient: male

Reactions: Somnolence

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-03

Patient: female

Reactions: Bipolar I Disorder, Drug Ineffective

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Intron A
    Dosage: unk;unk
    Indication: Hepatitis C
    Start date: 1991-01-01
    End date: 1991-04-01

Intron A
    Dosage: unk;unk
    Indication: Hepatitis C
    Start date: 2011-10-10



Possible Intron A side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-04

Patient: 51 year old female

Reactions: Pancreatitis Acute, Chills, Hyperhidrosis, Pallor, Pancreatitis Necrotising, Glomerulonephritis, Obesity, Chest Pain, Gastrooesophageal Reflux Disease, Renal Failure Acute, Refusal of Treatment by Patient, Type 2 Diabetes Mellitus, Blood Triglycerides Decreased, Hyponatraemia, Haemodialysis, Heart Rate Decreased, Skin Neoplasm Excision, Hypertension, Sleep Apnoea Syndrome, Influenza Like Illness

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Intron A
    Dosage: iv; iv
    Indication: Malignant Melanoma Stage III
    Start date: 2011-03-28
    End date: 2011-04-01

Intron A
    Dosage: iv; iv
    Indication: Malignant Melanoma Stage III
    Start date: 2011-03-21
    End date: 2011-03-25

Decadron

Other drugs received by patient: Compazine; Hydrochlorothiazide; Aspirin; Percocet; Norvasc

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012